UNSPSC 51422101: Prednisone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H26O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VB0R961HZT, chemically known as pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy- but generally known as prednisone, which bears US NIH Compound Identifier 4900. European Medicines Agency schedules Prednisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10020MIG.

UNSPSC 51422101 Prednisone is a Commodity code that appears in state and local procurement records primarily for naloxone and related emergency pharmaceutical products, though the code's nominal scope does not align closely with the recent solicitations tagged under it. State and local issuing bodies—including county health departments and state health and human services agencies—use this code to procure pharmaceutical products and related systems that support public health initiatives, community health services, and emergency response capabilities. The work being solicited includes naloxone units paired with drug deactivation systems for community health support and exploratory vendor engagement regarding direct-to-manufacturer pharmacy benefit programs.

Recent activity spans Florida and Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a response deadline of July 26, 2023; the contract includes a two-year initial term with an option for one-year renewal and carries potential FEMA funding with associated federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription fulfillment models for a Therapeutic Pharmacy Initiative program targeting self-insured employer and state agency health plans, seeking vendor experience with direct contracting, negotiated net pricing arrangements, and value-based agreements—a preliminary information-gathering phase intended to inform future formal solicitation strategy rather than an immediate procurement event.